Bernat Peguera A, Navarro Ventura J, Lorenzo Sanz L, da Silva Diz V, Bosio M, Palomero L, Penin RM, Sidelnikova DP, Bermejo JO, Taberna M, Vilarino N, Piulats JM, Mesia R, Vinals JM, Gonzalez Suarez E, Capella Gutierrez S, Villanueva A, Vinals F, Munoz P. FGFR Inhibition Overcomes Resistance to EGFR-targeted Therapy in Epithelial-like Cutaneous Carcinoma. Clin. Cancer Res. 2021;27(5):1491-1504. doi:10.1158/1078-0432.CCR-20-0232. IF:12,53.
Herranz C, Mateo F, Baiges A, de Garibay GR, Junza A, Johnson SR, Miller S, Garcia N, Capellades J, Gomez A, Vidal A, Palomero L, Espin R, Extremera AI, Blommaert E, Revilla Lopez E, Saez B, Gomez Olles S, Ancochea J, Valenzuela C, Alonso T, Ussetti P, Laporta R, Xaubet A, Rodriguez Portal JA, Montes Worboys A, Machahua C, Bordas J, Menendez JA, Cruzado JM, Guiteras R, Bontoux C, La Motta C, Noguera Castells A, Mancino M, Lastra E, Rigo Bonnin R, Perales JC, Vinals F, Lahiguera A, Zhang XH, Cuadras D, van Moorsel CHM, van der Vis JJ, Quanjel MJR, Filippakis H, Hakem R, Gorrini C, Ferrer M, Ugun Klusek A, Billett E, Radzikowska E, Casanova A, Molina M, Roman A, Yanes O, Pujana MA. Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis. EMBO Mol. Med. 2021;13(9):doi:10.15252/emmm.202113929. IF:12,14.
Cabot D, Brun S, Paco N, Ginesta MM, Gendrau Sanclemente N, Abuasaker B, Ruiz Farina T, Barcelo C, Cuatrecasas M, Bosch M, Rentero C, Pons G, Estanyol JM, Capella G, Jaumot M, Agell N. KRAS phosphorylation regulates cell polarization and tumorigenic properties in colorectal cancer. Oncogene. 2021;40(38):5730-5740. doi:10.1038/s41388-021-01967-3. IF:9,87.
Gomez Valenzuela F, Escobar E, Perez Tomas R, Montecinos VP. The Inflammatory Profile of the Tumor Microenvironment, Orchestrated by Cyclooxygenase-2, Promotes Epithelial-Mesenchymal Transition. Front. Oncol. 2021;11686792-686792. doi:10.3389/fonc.2021.686792. IF:6,24.
Hyrossova P, Arago M, Moreno Felici J, Fu XR, Mendez Lucas A, Garcia Roves PM, Burgess S, Figueras A, Vinals F, Perales JC. PEPCK-M recoups tumor cell anabolic potential in a PKC-zeta-dependent manner. Cancer Metab. 2021;9(1):1-1. doi:10.1186/s40170-020-00236-3. IF:5,47.